{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_metadata=all&answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "items" : [{"_about" : "http://data.parliament.uk/resources/1088418", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1088418/answer", "answerText" : {"_value" : "<p>NHS England is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. Scotland, Wales and Northern Ireland are in the process of setting up similar systems.<\/p><p> <\/p><p>In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector. We expect this data to be available by end of March 2019.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-21", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "232048"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-21T16:18:12.947Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207185 on Cannabis: Medical Treatments, whether data on prescriptions of cannabis-based medicinal products will (a) be published in the public domain, (b) include UK-wide data and (c) include the numbers of people obtaining a such a prescription.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "232047"}
    , {"_about" : "http://data.parliament.uk/resources/1088420", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1088420/answer", "answerText" : {"_value" : "<p>NHS England is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. Scotland, Wales and Northern Ireland are in the process of setting up similar systems.<\/p><p> <\/p><p>In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England Controlled Drug Accountable Officers are also collecting local intelligence in both the National Health Service and independent sector. We expect this data to be available by end of March 2019.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-21", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "232047"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-21T16:18:12.993Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-13", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 January 2019 to Question 207185 on Cannabis: Medical Treatments, whether data on prescriptions of cannabis-based medicinal products will include (a) the type of product prescribed, (b) the indication that product was prescribed for and (c) the number of those such prescriptions by NHS clinical commissioning group area.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4465", "label" : {"_value" : "Biography information for Ronnie Cowan"}
      }
      , "tablingMemberConstituency" : {"_value" : "Inverclyde"}
      , "tablingMemberPrinted" : [{"_value" : "Ronnie Cowan"}
      ], "uin" : "232048"}
    , {"_about" : "http://data.parliament.uk/resources/1083686", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1083686/answer", "answerText" : {"_value" : "<p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019. In Scotland, work is underway to establish similar systems.<\/p><p> <\/p><p>There are 95,532 specialist doctors registered on the General Medical Council\u2019s Specialist Register. The law allows any specialist doctor to prescribe cannabis-based products for medicinal use. Specialist doctors may decide to prescribe these products on a case-by-case basis, and where it is clinically appropriate. The Department does not hold information on how many of those practitioners operate private practices and are National Health Service or NHS Scotland employees or where they work.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "229805"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:17:58.713Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many patients have been prescribed cannabis-based products for medicinal use; and how many were (a) private prescriptions and (b) prescriptions funded by NHS or NHS Scottish.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"}
      , "tablingMemberPrinted" : [{"_value" : "Alan Brown"}
      ], "uin" : "229804"}
    , {"_about" : "http://data.parliament.uk/resources/1083687", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1083687/answer", "answerText" : {"_value" : "<p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019. In Scotland, work is underway to establish similar systems.<\/p><p> <\/p><p>There are 95,532 specialist doctors registered on the General Medical Council\u2019s Specialist Register. The law allows any specialist doctor to prescribe cannabis-based products for medicinal use. Specialist doctors may decide to prescribe these products on a case-by-case basis, and where it is clinically appropriate. The Department does not hold information on how many of those practitioners operate private practices and are National Health Service or NHS Scotland employees or where they work.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-03-12", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : {"_value" : "229804"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-03-12T16:17:58.773Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-03-07", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many medical practitioners are registered to prescribe cannabis-based products for medicinal use; how many of those practitioners (a) operate private practices and (b) are NHS or NHS Scotland employees; and if he will list the (i) Trusts and (ii) Health boards at which each of those NHS and NHS Scotland employee works.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4470", "label" : {"_value" : "Biography information for Alan Brown"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kilmarnock and Loudoun"}
      , "tablingMemberPrinted" : [{"_value" : "Alan Brown"}
      ], "uin" : "229805"}
    , {"_about" : "http://data.parliament.uk/resources/1063970", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1063970/answer", "answerText" : {"_value" : "<p>The decision to prescribe a cannabis-based product for medicinal use is one for individual clinicians to make, as part of a multidisciplinary team and in partnership with patients and their families.<\/p><p> <\/p><p>It would be inappropriate to second-guess the prescribing decisions of clinicians, who will be experts in their area and bear responsibility for prescribing.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-02-27", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-27T16:19:18.873Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-02-19", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent patients from being incorrectly denied access to medicinal cannabis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/478", "label" : {"_value" : "Biography information for Lord Field of Birkenhead"}
      }
      , "tablingMemberConstituency" : {"_value" : "Birkenhead"}
      , "tablingMemberPrinted" : [{"_value" : "Frank Field"}
      ], "uin" : "223142"}
    , {"_about" : "http://data.parliament.uk/resources/1055916", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1055916/answer", "answerText" : {"_value" : "<p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-02-14", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-02-14T17:29:40.15Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-02-06", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many people have accessed cannabis-derived medicinal products under schedule 2 of the Misuse of Drugs Regulations 2001.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4673", "label" : {"_value" : "Biography information for Jo Platt"}
      }
      , "tablingMemberConstituency" : {"_value" : "Leigh"}
      , "tablingMemberPrinted" : [{"_value" : "Jo Platt"}
      ], "uin" : "217660"}
    , {"_about" : "http://data.parliament.uk/resources/1039010", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1039010/answer", "answerText" : {"_value" : "<p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.<\/p><p> <\/p><p>The Department has made no estimate of future demand for medicinal cannabis over the next 12 months.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-01-18", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "207187"}
        , {"_value" : "207189"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-01-18T12:14:21.4Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many NHS prescriptons have been issued for patients to use medical cannabis since 1 November 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
      , "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
      ], "uin" : "207185"}
    , {"_about" : "http://data.parliament.uk/resources/1039016", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1039016/answer", "answerText" : {"_value" : "<p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.<\/p><p> <\/p><p>The Department has made no estimate of future demand for medicinal cannabis over the next 12 months.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-01-18", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "207185"}
        , {"_value" : "207189"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-01-18T12:14:21.447Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many NHS prescriptions have been honoured at a pharmacy for patients to use medical cannabis since 1 November 2018.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
      , "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
      ], "uin" : "207187"}
    , {"_about" : "http://data.parliament.uk/resources/1039029", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1039029/answer", "answerText" : {"_value" : "<p>NHS England has set up systems to monitor the prescribing of cannabis-based products for medicinal use via the NHS Business Services Authority and NHS England Controlled Drugs Accountable Officers. We expect the first data to be available by the end of March 2019.<\/p><p> <\/p><p>The Department has made no estimate of future demand for medicinal cannabis over the next 12 months.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-01-18", "_datatype" : "dateTime"}
        , "groupedQuestionUIN" : [{"_value" : "207185"}
        , {"_value" : "207187"}
        ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-01-18T12:14:21.51Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of (a) prescriptions issued and (b) patients that use medical cannabis in the next 12 months.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
      , "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
      ], "uin" : "207189"}
    , {"_about" : "http://data.parliament.uk/resources/1039035", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1039035/answer", "answerText" : {"_value" : "<p>Officials in the Department have worked with colleagues in NHS England, the Medicines and Healthcare products Regulatory Agency, the Home Office and individual National Health Service trusts, as necessary, to ensure that individual patients can access cannabis-based medicinal products where specialist doctors have decided this would be clinically beneficial.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
        }
        , "answeringMemberConstituency" : {"_value" : "Winchester"}
        , "answeringMemberPrinted" : {"_value" : "Steve Brine"}
        , "dateOfAnswer" : {"_value" : "2019-01-18", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2019-01-18T12:12:16.05Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2019-01-10", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Cannabis: Medical Treatments"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions (a) he, (b) Ministers in his Department and (c) officials in his Department with NHS Trusts on implementing adequate measures to ensure access to medical cannabis for patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1528", "label" : {"_value" : "Biography information for Sir Mike Penning"}
      }
      , "tablingMemberConstituency" : {"_value" : "Hemel Hempstead"}
      , "tablingMemberPrinted" : [{"_value" : "Sir Mike Penning"}
      ], "uin" : "207190"}
    ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answer.answeringMember.label=Biography+information+for+Steve+Brine&hansardHeading=Cannabis%3A+Medical+Treatments", "page" : 0, "startIndex" : 1, "totalResults" : 25, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}